By Professor Phillip David Stricker

Conference Posters

Nieboer D; de Vos I; Lee LS; Stricker P; Frydenburg M; Bjartell A; Rubio-Briones J; Semjonow A; Rannikko A; van Hemelrijck M; Pavlovich C; Carroll P; Roobol M, 2022, 'MP43-14 EXTERNAL VALIDATION OF A MODEL PREDICTING INCREASE IN GLEASON GRADE FOR MEN ON ACTIVE SURVEILLANCE IN THE GAP3 CONSORTIUM DATABASE', Vol. 207, http://dx.doi.org/10.1097/ju.0000000000002609.14

Joshua AM; Stricker P; Epstein RJ; Ho B; Quoc N; Kent R; Willowson KP; Hofman M; Violet JA; Emmett L, 2017, 'Patterns of failure on Ga PSMA (GaPSMA) and F18 FDG (FDG) PET CT in a prospective phase 2 trial of Lu-177 DKFZ PSMA 617 (LuPSMA) in men with castrate resistant metastatic prostate cancer (mCRPC)', IL, Chicago, Vol. 35, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.2562

Back to profile page